Sachiko Iseki
Papers
2
Total Citations
320
H-Index
2
About
Sachiko Iseki is a pioneering researcher in the emerging field of plasma medicine, with a primary focus on the selective induction of apoptosis in cancer cells using nonequilibrium atmospheric pressure plasma (NEAPP). Her major contribution lies in demonstrating that NEAPP can selectively kill ovarian cancer cells while sparing normal fibroblast controls, a breakthrough that opens new avenues for targeted cancer therapies. In her landmark 2012 study, which has garnered 314 citations, Iseki showed that continuous plasma treatment effectively detached ovarian cancer cells from culture dishes and triggered programmed cell death, highlighting the potential of plasma as a non-invasive, localized treatment modality. This work underscores her impact on the intersection of physics and oncology, offering a novel approach to cancer treatment that minimizes damage to healthy tissues. Iseki’s research has been instrumental in advancing the understanding of plasma-induced apoptosis, and her findings continue to inspire further investigations into the clinical applications of atmospheric pressure plasmas. Her contributions have established her as a key figure in the development of plasma-based cancer therapies.
Research Focus
Key Achievements
Top Papers
- 1
- 2